Home
Drugs
Oxaliplatin
Clinical Trials

Clinical Trials Related to Oxaliplatin

Related studies linked through entity extraction aliases.

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Status: RECRUITING
Phase: PHASE1/PHASE2

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

Status: RECRUITING
Phase: PHASE2

A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)

Status: RECRUITING
Phase: PHASE2

Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

FOLFIRINOX + NIS793 in Pancreatic Cancer

Status: TERMINATED
Phase: PHASE1

SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer

Status: RECRUITING
Phase: PHASE1

A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE1

A Study of ASP3082 in Adults With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Status: RECRUITING
Phase: PHASE1

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Status: RECRUITING
Phase: PHASE1

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Status: UNKNOWN
Phase: PHASE2

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Status: UNKNOWN
Phase: PHASE2

A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab

Status: RECRUITING
Phase: PHASE1/PHASE2

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

Status: NOT_YET_RECRUITING
Phase: PHASE3

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC

Status: UNKNOWN
Phase: PHASE2

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Status: WITHDRAWN
Phase: PHASE1